Healio Hot Topic

Medical Management of IBS is Improving With Time

Healio Gastroenterology, October 2019
Mark Pimentel, MD
In my clinic, it still feels like we get countless referrals for irritable bowel syndrome. We have gained so much knowledge and obtained so many new…

Healio Hot Topic

Many Options Available for Patients With Refractory IBS

Healio Gastroenterology, October 2019
Anthony J. Lembo, MD
By the time a patient with irritable bowel syndrome gets to a tertiary referral physician like me, they have likely tried a lot of treatments…

Healio Hot Topic

IBS Care Limited by Patient Access to Medicine

Healio Gastroenterology, October 2019
Eric D. Shah, MD, MBA
More than 30 million people in the United States have irritable bowel syndrome. In diarrhea-predominant irritable bowel syndrome, there are several…

Meeting News

Vagal efficiency predicts response to external neurostimulation for abdominal pain

October 18, 2019
CHICAGO — Measuring vagal efficiency through respiratory sinus arrythmia in patients with functional abdominal pain could help predict…

In the Journals

External neurostimulation reduces pain scores in children with IBS

October 16, 2019
A non-invasive device that delivers neurostimulation to the external ear reduced pain scores and improved overall well-being in children with…

Healio announces its Disruptive Innovators finalists

October 4, 2019
SAN ANTONIO — Healio will host its second Disruptive Innovators reception during the American College of Gastroenterology’s Annual…

In the Journals

AGA issues new chronic diarrhea guidelines

September 27, 2019
The American Gastroenterological Association released new clinical practice guidelines for the evaluation of chronic diarrhea. Specifically, the…

FDA News

7 recent FDA updates you may have missed

September 20, 2019
Healio Gastroenterology and Liver Disease has compiled a list of some of the most recent approvals and updates from the FDA. Our readers were most…

FDA NewsPerspective

FDA approves Ibsrela for IBS-C in adults

September 13, 2019
The FDA on Thursday approved Ibsrela, a 50 mg, twice-daily oral therapy for irritable bowel syndrome with constipation in adults. “Ibsrela has…

By the Numbers

5 recent highlights in IBS

September 6, 2019
Recently published studies have demonstrated new developments in diarrhea- and constipation-predominant irritable bowel syndrome, as well as…

In the Journals

Peppermint oil ‘should not be ignored’ for IBS

August 29, 2019
Although it did not meet stringent recommended endpoints dictated by the FDA and European Medicines Agency, small intestinal-release peppermint oil…

IBgard releases data to show safety, tolerability of peppermint oil for IBS

August 23, 2019
In a post-marketing study, the manufacturer of IBgard showed that over-the-counter peppermint oil treatment effectively managed symptoms of irritable…

In the Journals

GI, psychological symptoms overlap in IBS-D, functional diarrhea

August 21, 2019
Researchers from Beth Israel Deaconess Medical Center identified an overlap of gastrointestinal and psychosomatic symptoms between patients with…

In the Journals

Patients with IBS-D, IBS-C find their lives impacted in different ways

August 15, 2019
Although patients with diarrhea- and constipation-predominant irritable bowel syndrome tend to find their condition equally bothersome, they find…

Mayo Clinic ranked best hospital for adult gastrointestinal care

July 30, 2019
Mayo Clinic tops U.S. News & World Report’s 2019-2020 Best Hospitals rankings for adult gastroenterology and gastrointestinal surgery…

In the Journals

Fecal transplant no better than placebo for IBS-D

July 29, 2019
Researchers cut a trial short after fecal microbiota transplantation failed to provide symptom relief better than that of placebo in patients with…

First patient dosed in GI disorder-associated pain trial

July 27, 2019
Arena Pharmaceuticals announced that the first patient has been dosed in the phase 2 CAPTIVATE trial, according to a company press release. The…

In the Journals

Psychiatric symptoms inconsistently predict health care use for patients with IBS

July 25, 2019
Patients with irritable bowel syndrome and psychiatric comorbidities are more likely to seek psychiatric care but not gastrointestinal care when they…

AGA, FDA met to discuss fecal transplant regulation: What you need to know

July 25, 2019
Several members of the American Gastroenterological Association recently met with representatives from the FDA’s Center for Biologics…

In the Journals

Depression linked to increased IBD activity

July 19, 2019
Researchers found that depression was independently associated with greater inflammatory bowel disease, or IBD, activity, and that less positive…